Literature DB >> 16418839

Phosphate concentration in artificial tears.

W Bernauer1, M A Thiel, U M Langenauer, K M Rentsch.   

Abstract

BACKGROUND: Irrigating solutions and eye drops may contain phosphates as part of their buffer system. In the presence of epithelial keratopathy, a high concentration of phosphate favours corneal calcification. Knowledge of the phosphate concentration in artificial tear products helps to prevent this sight-threatening complication. This study gives an overview on the amount of phosphate contained in artificial tears.
METHODS: Fifty-nine samples of commercially available artificial tear preparations were tested. The quantification of phosphate was performed using the molybdate method on a Modular P autoanalyzer.
RESULTS: Twenty-six of 59 (44%) artificial tear products had a phosphate concentration above physiological levels (>1.45 mmol/l). A phosphate concentration above 25 mmol/l was found in nine products (15%), a concentration higher than 50 mmol/l in three (5%).
CONCLUSIONS: Many artificial tear formulations contain unphysiological levels of phosphate, but very high concentrations are found only in a few products. These preparations have the potential to favour the formation of insoluble crystalline calcium phosphate deposits when used on a damaged corneal surface, and should therefore be used cautiously.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418839     DOI: 10.1007/s00417-005-0219-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  Acute corneal calcification following chemical injury.

Authors:  Mary Daly; Stephen J Tuft; Peter M G Munro
Journal:  Cornea       Date:  2005-08       Impact factor: 2.651

2.  Analytical performance of the random access analyser Hitachi 737. A multicentre evaluation.

Authors:  M Knedel; R Haeckel; D Seidel; J Thiery; D J Vonderschmitt; E Haenseler
Journal:  J Clin Chem Clin Biochem       Date:  1986-06

3.  Corneal stromal calcification after topical steroid-phosphate therapy.

Authors:  U Schlötzer-Schrehardt; Z Zagórski; L M Holbach; C Hofmann-Rummelt; G O Naumann
Journal:  Arch Ophthalmol       Date:  1999-10

4.  Phosphate buffer in alkali eye burns as an inducer of experimental corneal calcification.

Authors:  N F Schrage; B Schlossmacher; W Aschenbernner; S Langefeld
Journal:  Burns       Date:  2001-08       Impact factor: 2.744

5.  Corneal calcification following intensified treatment with sodium hyaluronate artificial tears.

Authors:  W Bernauer; M A Thiel; M Kurrer; A Heiligenhaus; K M Rentsch; A Schmitt; C Heinz; A Yanar
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

6.  Acute band keratopathy following intracameral Viscoat.

Authors:  A S Nevyas; I M Raber; R C Eagle; I B Wallace; H J Nevyas
Journal:  Arch Ophthalmol       Date:  1987-07

Review 7.  Corneal cytotoxicity of topically applied drugs, vehicles and preservatives.

Authors:  N L Burstein
Journal:  Surv Ophthalmol       Date:  1980 Jul-Aug       Impact factor: 6.048

8.  Acute calcification in alkali-injured rabbit cornea treated with synthetic inhibitor of metalloproteinases (SIMP).

Authors:  Y Huang; K M Meek; H Mangat; C A Paterson
Journal:  Cornea       Date:  1998-07       Impact factor: 2.651

  8 in total
  6 in total

1.  [Phosphate in ophthalmologic solutions].

Authors:  W Bernauer; M A Thiel; K M Rentsch
Journal:  Ophthalmologe       Date:  2006-05       Impact factor: 1.059

2.  Dry eye and designer ophthalmics.

Authors:  Gordon W Laurie; Leslie A Olsakovsky; Brian P Conway; Robert L McKown; Kazuko Kitagawa; Jason J Nichols
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

3.  Phosphate concentration in ophthalmic corticoid preparations.

Authors:  W Bernauer; M A Thiel; K M Rentsch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-21       Impact factor: 3.117

4.  Comparative analysis of human conjunctival and corneal epithelial gene expression with oligonucleotide microarrays.

Authors:  Helen C Turner; Murat T Budak; M A Murat Akinci; J Mario Wolosin
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

5.  Implications for Ophthalmic Formulations: Ocular Buffers Show Varied Cytotoxic Impact on Human Corneal-Limbal and Human Conjunctival Epithelial Cells.

Authors:  Nadine Schuerer; Elisabeth Stein; Aleksandra Inic-Kanada; Marion Pucher; Christine Hohenadl; Nora Bintner; Ehsan Ghasemian; Jacqueline Montanaro; Talin Barisani-Asenbauer
Journal:  Cornea       Date:  2017-06       Impact factor: 2.651

6.  Assessment of Phosphate and Osmolarity Levels in Chronically Administered Eye Drops

Authors:  Onur Özalp; Eray Atalay; İbrahim Özkan Alataş; Zeynep Küskü Kiraz; Nilgün Yıldırım
Journal:  Turk J Ophthalmol       Date:  2019-06-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.